Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
This study is ongoing, but not recruiting participants.
Study NCT00022178 Information provided by National Cancer Institute (NCI)
First Received: August 10, 2001 Last Updated: August 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma of Unknown Primary
Additional conditions recognized in this trial
Carcinoma
Neoplasms, Unknown Primary
More general conditions related to this trial
Neoplasm Metastasis
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
cisplatin
cyclophosphamide
doxorubicin hydrochloride
epirubicin hydrochloride
fluorouracil
vincristine sulfate
Additional drug interventions recognized in this trial
Doxorubicin
Epirubicin
Vincristine
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Christie Hospital NHS Foundation Trust
Back to top of Main Content
